ACAN Oblitoxaximab injection
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
Public Services and Procurement Canada, on behalf of the Public Health Agency of Canada, has issued an Advanced Contract Award Notice for the procurement of Oblitoxaximab injection, an antitoxin used in the treatment of inhalation anthrax. The government intends to negotiate a contract with Elusys Therapeutics, Inc. unless other suppliers can demonstrate equivalent capabilities by the specified deadline. The solicitation, numbered WS5994329939, was posted on November 17, 2026, with a response deadline of December 8, 2026. This procurement is managed by the Department of Public Works and Government Services for performance within Canada. There is no specified set-aside status for this requirement.
General Info
Place of Performance
Canada, CANSet-Aside
Documents
0No documents available
Documents will appear here when they are available.
AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Get what you need to respond
No documents were posted with this contract.
- Buyer contactEmail
- Original solicitationLink to the source posting
Ask CLEATUS
I've read this contract. Ask me anything.
Timeline
Solicitation
Submission deadline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Government of Canada → Department of Public Works and Government Services
Same awarding agency
Get AI-powered intelligence on this solicitation and the ones like it
Every solicitation package arrives shredded into a compliance breakdown and matched to your past performance, with incumbent history and alerts on amendments and award.
Join 750+ contractors already using CLEATUS
